Intrahospital Transport in Patients With High-flow Nasal Oxygenation: Prospective Observational Study

Centre Hospitalier Régional d'Orléans175 enrolled

Overview

High-flow nasal oxygen therapy is commonly used in intensive care unit (ICU). Intra-hospital transfer of critical patients is frequent: 1) to perform diagnostic 2) between emergency room or medical wards and ICU. During theses transfers, oxygenation should be continued. There is high-flow nasal oxygen therapy for transport using an external battery. This mode of operation in transport mode allows about 30-45 min of autonomy. Intra-hospital transport under high-flow nasal oxygen therapy has been previously described on children. The objective of this study is to evaluate the occurrence of complications during intra-hospital transports under high-flow nasal oxygen of critical patients.

Study Type

OBSERVATIONAL

Enrollment

175

Conditions

Critical Illness

Interventions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient treated with high-flow nasal oxygen therapy before the intra-hospital transport prior to transport * Requiring an intra-hospital transport (e.g., CT scan, OR, etc.) or inter-departmental transport supervised by the ICU team Nb: Once the patient is included in the study, any intra-hospital transport under high-flow nasal oxygen therapy will be analyzed until discharge from the intensive care unit and at until D28. Exclusion Criteria: * Under 18 years old * Patient being under guardianship, tutorship or curatorship * Pregnancy or breastfeeding * Lack of social security number * Refusal to participate in the study

Locations (4)

Hospital Center of DAX

Dax, France

CH de Martigues

Martigues, France

CHU Orléans

Orléans, France

CH Bretagne Atlantique vannes-Auray

Vannes, France

Outcomes

Primary Outcomes

Incidence of severe adverse events during intra-hospital transport

To evaluate the incidence of severe adverse events during intra-hospital transport of patients treated with high-flow nasal oxygen surpervised by an ICU staff. Severe adverse event is defined by the occurrence of intubation during transport or severe hypoxemia defined as pulse oxygen saturation (SpO2 \< 80%) or cardiorespiratory arrest.

Time frame: Up to 28 days

Secondary Outcomes

Incidence of minor adverse events during intra-hospital transport

To evaluate the incidence of minor adverse events during intra-hospital transport of patients treated with high-flow nasal oxygen surpervised by an ICU staff. Minor adverse event is defined by the occurrence of the need to increase the FiO2 or a pull-out of nasal cannulas or the use of an alternative mode of oxygenation (standard oxygen or noninvasive ventilation) or a failure of high-flow nasal oxygenation system (ie battery failure)

Time frame: Up to 28 days